Suppr超能文献

熊去氧胆酸:一种安全有效的溶解胆固醇结石的药物。

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.

作者信息

Tint G S, Salen G, Colalillo A, Graber D, Verga D, Speck J, Shefer S

出版信息

Ann Intern Med. 1982 Sep;97(3):351-6. doi: 10.7326/0003-4819-97-3-351.

Abstract

Ursodeoxycholic acid, 250 to 300, 500 to 600, or 900 to 1000 mg/d, was given orally for 6 to 38 months to 53 patients with cholesterol gallstones and functioning gallbladders. Forty-two patients had greater than 50% reduction in gallstone volume, number, or both, without apparent dose dependence and 27 of these patients had complete gallstone dissolution. Results of laboratory studies including liver function tests were not affected adversely and biliary lithocholic acid concentration did not increase during therapy. Most biliary symptoms seemed to disappear within 3 months and no patient developed diarrhea. Large diameter and increased number of gallstones were found to hinder dissolution. The percentage of biliary ursodeoxycholic acid increased with increasing dose and reached a maximum of 50% to 60% of total bile acids at a dose of about 10 to 12 mg/kg body weight. d. Biliary lithogenic index was reduced significantly during treatment with ursodeoxycholic acid, 500 to 600 and 900 to 1000 mg/d. Thus, ursodeoxycholic acid appears to be a safe and effective alternative to surgery in selected patients with gallstones.

摘要

对53例患有胆固醇性胆结石且胆囊功能正常的患者口服熊去氧胆酸,剂量为250至300毫克/天、500至600毫克/天或900至1000毫克/天,疗程为6至38个月。42例患者的胆结石体积、数量或两者均减少了50%以上,且无明显剂量依赖性,其中27例患者胆结石完全溶解。包括肝功能检查在内的实验室研究结果未受到不利影响,治疗期间胆汁石胆酸浓度未升高。大多数胆部症状似乎在3个月内消失,没有患者出现腹泻。发现胆结石直径大及数量多会阻碍溶解。胆汁中熊去氧胆酸的百分比随剂量增加而升高,在剂量约为10至12毫克/千克体重时达到总胆汁酸的50%至60%的最大值。用500至600毫克/天和900至1000毫克/天的熊去氧胆酸治疗期间,胆汁成石指数显著降低。因此,对于某些胆结石患者,熊去氧胆酸似乎是一种安全有效的手术替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验